[ESPR] QoQ Quarter Result on 30-Jun-2015 [#Q2]

Stock
[ESPR] Esperion Therapeutics, Inc.
Announcement Date
06-Aug-2015
Financial Year
2015
Quarter
30-Jun-2015 [#Q2]
Profit Trend
QoQ- -8.10%
YoY- -34.17%
Quarter Report
ESPR's Result
ESPR's Financial Summary
View:
Show?
Quarter Result
31/03/16 31/12/15 30/09/15 30/06/15 31/03/15 31/12/14 30/09/14 CAGR
Revenue 0 0 0 0 0 0 0 -
PBT -14,585 -13,122 -12,801 -12,395 -11,466 -9,457 -9,806 30.26%
Tax 457 287 378 337 227 135 164 97.89%
NP -14,585 -13,122 -12,801 -12,395 -11,466 -9,457 -9,806 30.26%
Tax Rate - - - - - - - -
Total Cost 14,585 13,122 12,801 12,395 11,466 9,457 9,806 30.26%
Ratio Analysis
31/03/16 31/12/15 30/09/15 30/06/15 31/03/15 31/12/14 30/09/14 CAGR
NP Margin 0.00 0.00 0.00 0.00 0.00 0.00 0.00 -
Per Share
31/03/16 31/12/15 30/09/15 30/06/15 31/03/15 31/12/14 30/09/14 CAGR
EPS -0.65 -0.58 -0.57 -0.55 -0.56 -0.49 -0.64 1.03%
EPS Diluted -0.65 -0.58 -0.57 -0.55 -0.56 -0.49 -0.64 1.03%

PBT = Profit before Tax, NP = Net Profit, NP Margin = Net Profit Margin, EPS = Earning Per Share, EPS Diluted = Earning Per Share Diluted.

NP Margin, QoQ ⃤ & YoY ⃤ figures in Percentage; EPS & EPS Diluted figures in Cent.

All figures in '000 unless specified.